Kondo Keita, Kato Aya, Niwa Toshiyuki
Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan.
Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan.
Int J Pharm. 2015 Apr 10;483(1-2):101-9. doi: 10.1016/j.ijpharm.2015.02.026. Epub 2015 Feb 11.
We established an extremely high-shear melt pelletization technique using a mechanical powder processor to produce high-dose granules smaller than 300 μm with properties suitable for film coating. A mixture of ethenzamide and polyethylene glycol (used as a low-melting binder) at various weight ratios was mechanically treated under various jacket temperatures. When the jacket temperature was set to 50 °C or greater, the product temperature reached the melting point of the binder, resulting in pelletization. The drug powder were pelletized with a small amount of binder to yield pellets of approximately 150 μm with a drug content of more than 90%. The mechanism of melt pelletization through ultrahigh shearing involves a series of nucleation, consolidation, coalescence and breakage stages. The power consumption profile corresponding to each stage in the pelletization revealed that pellets between 75 and 300 μm were effectively obtained at a large power consumption peak. The resultant pellets showed comparative sphericity and smoothness, and higher durability than commercial core granules for film coating. In conclusion, this study demonstrates that the extremely high-shear melt pelletization technique can give drug pellets with desirable properties as core particles for the coating process.
我们使用机械粉末处理器建立了一种极高剪切力熔融造粒技术,以生产尺寸小于300μm且具有适合薄膜包衣特性的高剂量颗粒。将乙水杨胺和聚乙二醇(用作低熔点粘合剂)按不同重量比混合,在不同夹套温度下进行机械处理。当夹套温度设定为50℃或更高时,产品温度达到粘合剂的熔点,从而实现造粒。药物粉末与少量粘合剂一起造粒,得到药物含量超过90%、粒径约为150μm的颗粒。通过超高剪切力进行熔融造粒的机制涉及一系列成核、固结、聚结和破碎阶段。造粒过程中每个阶段对应的功耗曲线表明,在较大的功耗峰值下可有效获得75至300μm的颗粒。所得颗粒显示出相对的球形度和平滑度,并且比商业薄膜包衣用的核心颗粒具有更高的耐久性。总之,本研究表明,极高剪切力熔融造粒技术可制得具有理想特性的药物颗粒作为包衣过程的核心颗粒。